| Mendenhall WM, Riggs CE, Vaysberg M, et al.
Altered fractionation and adjuvant chemotherapy for head and neck squamous cell carcinoma. [JOURNAL ARTICLE]
Head Neck 2009 Nov 5.
Abstract | Full Citation | Find Related Articles | | Ray M, Salgia R, Vokes EE
The Role of EGFR Inhibition in the Treatment of Non-Small Cell Lung Cancer. [JOURNAL ARTICLE]
Oncologist 2009 Nov 5.
Abstract | Full Citation | Find Related Articles | | Nishiyama M, Wada S
Docetaxel: its role in current and future treatments for advanced gastric cancer. [Journal Article]
Gastric Cancer 2009; 12(3):132-41.
Abstract | Full Citation | | Larbouret C, Robert B, Bascoul-Mollevi C, et al.
Combined cetuximab and trastuzumab are superior to gemcitabine in the treatment of human pancreatic carcinoma xenografts. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 4.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Tai CJ, Hsu CH, Wang FJ, et al.
Weekly cetuximab and gemcitabine plus cisplatin as salvage therapy for unresectable non-small cell lung cancer. [Letter]
Onkologie 2009 Nov; 32(11):685-6.
Full Citation | Find Related Articles | | Laurent-Puig P, Cayre A, Manceau G, et al.
Analysis of PTEN, BRAF, and EGFR Status in Determining Benefit From Cetuximab Therapy in Wild-Type KRAS Metastatic Colon Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Smith RA, Yuan H, Weissleder R, et al.
A Wortmannin-Cetuximab as a Double Drug. [JOURNAL ARTICLE]
Bioconjug Chem 2009 Nov 2.
Abstract | Full Citation | | Cleary JM, Tanabe KT, Lauwers GY, et al.
Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver. [JOURNAL ARTICLE]
Oncologist 2009 Oct 30.
Abstract | Full Citation | Find Related Articles | | Kim R
Cetuximab and panitumumab: are they interchangeable? [LETTER]
Lancet Oncol 2009 Oct 27.
Full Citation | Find Related Articles | | Paule B, Castagne V, Picard V, et al.
MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer. [JOURNAL ARTICLE]
Med Oncol 2009 Oct 28.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
